Evidence map›Paper›PMID 25243064›Full record

ArticleTreatment strategies. Diabetes2011

Chromium Picolinate for the Prevention of Type 2 Diabetes.

Ather Ali, Yingying Ma, Jesse Reynolds, John Pierce Wise, Silvio E Inzucchi, David L Katz

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in Treatment strategies. Diabetes, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Ather AliAssistant Director, Integrative Medicine, Prevention Research Center, Yale University School of Medicine.
Yingying MaAssistant Director, Vascular Research Lab, Prevention Research Center, Yale University School of Medicine.
Jesse ReynoldsData Analyst, Prevention Research Center, Yale University School of Medicine.
John Pierce WiseProfessor of Toxicology and Molecular Epidemiology, University of Southern Maine.
Silvio E InzucchiProfessor of Medicine (Endocrinology), Department of Internal Medicine, Yale University School of Medicine.
David L KatzDirector, Prevention Research Center, Yale University School of Medicine.
Yale University · USIntegrative Medicine Institute · USPrevention Institute · USUniversity of Southern Maine · USYale Griffin Prevention Research Center · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Meeting Community Needs Across the Prevention SpectrumU48DP000053 · DP · YALE UNIVERSITY · PI CLEARY, PAUL D · 2004 to 2008
$2.2M
Chromium Effects in Imparied Glucose ToleranceR21AT001332 · NCCIH · GRIFFIN HEALTH SRVS CORP-GRIFFIN HOSP · PI KATZ, DAVID L · 2003 to 2006
$427k
Research Training in Integrative MedicineF32AT002667 · NCCIH · GRIFFIN HEALTH SRVS CORP-GRIFFIN HOSP · PI ALI, ATHER · 2005 to 2007
$169k
NCCDPHP CDC HHS U48 DP000053NCCIH NIH HHS F32 AT002667NCCIH NIH HHS L30 AT004887NCCIH NIH HHS R21 AT001332NCRR NIH HHS UL1 RR024139
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID25243064
PMCPMC4169208
OpenAlexW1264204418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.